Patents Assigned to VERISKIN, INC.
  • Skin perfusion monitoring device
    Patent number: 11826130
    Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: November 28, 2023
    Assignee: VERISKIN, INC.
    Inventors: Mirianas Chachisvilis, Carl Frederick Edman, Eugene Tu
  • Skin perfusion monitoring device
    Patent number: 11089969
    Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: August 17, 2021
    Assignee: VERISKIN, INC.
    Inventors: Mirianas Chachisvilis, Carl Frederick Edman, Eugene Tu